Zai Lab Ltd ( ZLAB ) – ADR shares are trading higher by 3.45% to $27.59 during Friday’s session. The company priced a $200 million public offering of 7,843,137 shares at $25.50 per ADS.

The offering is expected to close on November 18, subject to customary conditions. The company has also granted underwriters a 30-day option to purchase an additional 1,176,470 ADSs.

Net proceeds will be used for general corporate purposes. Goldman Sachs, Jefferies and Leerink Partners are the joint book-running managers for the offering.

Read Also: Just Before Biden’s Term Ends, Taiwan Semiconductor Lands $6.6 Billion in US Funding to Build Advanced Chip Plants

How To Buy ZLAB Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instruments.

For example, in Zai Lab’s case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

According to data from Benzinga Pro, ZLAB has a 52-week high of $36.50 and a 52-week low of $13.48.